Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders

Jeffrey J. Wilson, Frances R. Levin

Journal of Child and Adolescent Psychopharmacology. Nov 2005, Vol. 15, No. 5: 751-763

Psychostimulant Treatment and Risk for Substance Abuse Among Young Adults with a History of Attention-Deficit/Hyperactivity Disorder: APopulation-Based, Birth Cohort Study

Slavica K. Katusic, William J. Barbaresi, Robert C. Colligan, Amy L. Weaver, Cynthia L. Leibson, Steven J. Jacobsen

Journal of Child and Adolescent Psychopharmacology. Nov 2005, Vol. 15, No. 5: 764-776

Bupropion SR for the Treatment of Substance- Abusing Outpatient Adolescents with Attention- Deficit/Hyperactivity Disorder and Mood Disorders

Ramon Solhkhah, Timothy E. Wilens, Jeanine Daly, Jefferson B. Prince, Stephanie L. Van Patten, Joseph Biederman

Journal of Child and Adolescent Psychopharmacology. Nov 2005, Vol. 15, No. 5: 777-786

The Clinical Dilemma of Using Medications in Substance-Abusing Adolescents and Adults with Attention-Deficit/Hyperactivity Disorder: What Does the Literature Tell Us?

Timothy E. Wilens, Michael C. Monuteaux, Lindsey E. Snyder, Hadley Moore, Julia Whitley, Martin Gignac

Journal of Child and Adolescent Psychopharmacology. Nov 2005, Vol. 15, No. 5: 787-798

Attention-Deficit/Hyperactivity Disorder, Medication Treatment, and Substance Use Patterns Among Adolescents and Young Adults

Himanshu P. Upadhyaya, Kelly Rose, Wei Wang, Kathleen O'Rourke, Brian Sullivan, Deborah Deas, Kathleen T. Brady

Journal of Child and Adolescent Psychopharmacology. Nov 2005, Vol. 15, No. 5: 799-809

Pharmacotherapy of Adolescent Substance Use Disorders: AReview of the Literature

James G. Waxmonsky, Timothy E. Wilens

Journal of Child and Adolescent Psychopharmacology. Nov 2005, Vol. 15, No. 5: 810-825

Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders
Malone RP, Gratz SS, Delaney MA, Hyman SB

CNS Drugs. 2005;19(11):923-34

Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study
Rosenberg DR, Macmaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P

Biol Psychiatry. 2005 Nov 1;58(9):700-4. Epub 2005 Aug 8

Sex Differences in the Brain: Implications for Explaining Autism

Simon Baron-Cohen, Rebecca C. Knickmeyer, Matthew K. Belmonte

Science, Vol 310, Issue 5749, 819-823 , 4 November 2005

Testing assumptions for endophenotype studies in ADHD: Reliability and validity of tasks in a general population sample
Jonna Kuntsi, Penny Andreou, Jonathan Ma, Norbert A Borger and Jaap J van der Meere
BMC Psychiatry 2005, 5:40; 1 November 2005

Treatment of depression in children and adolescents

Neal D Ryan

The Lancet. Volume 366, Issue 9489, September 2005, Pages 933-940

Neonatal factors in infants with Autistic Disorder and typically developing infants

Yoko Sugie, Hideo Sugie, Tokiko Fukuda, Masataka Ito

Autism, Vol. 9, No. 5, 487-494 (2005)

Prepubertal Bipolar Disorder: Proper Diagnosis Should Lead to Better Treatment Response
Edith M Jolin, Elizabeth B Weller and Ronald A Weller
Current Psychosis & Therapeutics Reports 2005, 3:103-110

Pilot Study: Fluvoxamine Treatment for Depression and Anxiety Disorders in Children and Adolescents with Cancer
Gothelf, Doron; Rubinstein, Maly; Shemesh, Eyal; Miller, Orit; Farbstein, Ilana; Klein, Anat; Weizman, Abraham; Apter, Alan; Yaniv, Isaac

Journal of the American Academy of Child & Adolescent Psychiatry. 44(12):1258-1262, December 2005

Fluoxetine for the Treatment of Childhood Anxiety Disorders: Open-Label, Long-Term Extension to a Controlled Trial
Clark, Duncan; Birmaher, Boris; Axelson, David; Monk, Kelly; Kalas, Catherine; Ehmann, Mary; Bridge, Jeffrey; Wood, D Scott; Muthen, Bengt; Brent, David

Journal of the American Academy of Child & Adolescent Psychiatry. 44(12):1263-1270, December 2005

Brain Magnetic Resonance Spectroscopy in Tourette's Disorder.
DEVito, Timothy J; Drost, Dick J; Pavlosky, William; Neufeld, Richard W. J; Rajakumar, Nagalingam; MCKinlay, B Duncan; Williamson, Peter C; Nicolson, Rob

Journal of the American Academy of Child & Adolescent Psychiatry. 44(12):1301-1308, December 2005

Association between Dopamine Transporter (DAT1) Genotype, Left-Sided Inattention, and an Enhanced Response to Methylphenidate in Attention-Deficit Hyperactivity Disorder
Mark A Bellgrove, Ziarih Hawi, Aiveen Kirley, Michael Fitzgerald, Michael Gill and Ian H Robertson

Neuropsychopharmacology (2005) 30, 2290-2297

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Children and Adolescents: Update on New Stimulant Preparations, Atomoxetine, and Novel Treatments

Jefferson B. Prince

Child Adol Psych Clin NA 2005; 15(1):Pages 13-50

Comparative Efficacy of Cognitive Behavioral Therapy, Fluoxetine, and Their Combination in Depressed Adolescents: Initial Lessons from the Treatment for Adolescents with Depression Study

Sanjeev Pathak, Christopher J. Kratochvil, Gregory M. Rogers, Susan Silva, Benedetto Vitiello, Elizabeth B. Weller, and John S. March

Current Psychiatry Reports 2005, 7:429-434

Regresar a RESÚMENES NOVIEMBRE 2005